InterMed Discovery Announces Collaboration Agreement With the Lead Discovery Center

06-Apr-2009 - Germany

InterMed Discovery (IMD announced the start of a screening project for the lead discovery Center GmbH (LDC), a Max-Planck-Innovation company. The LDC was founded in 2008 in close proximity to IMD at the University Campus at Dortmund and forms an essential part of Max-Planck-Innovation's Drug Discovery & Development Center (DDC).

The objective of this collaboration project between IMD and the LDC is to identify naturally derived modulators by screening IMD’s natural product libraries against targets provided by LDC and based on intellectual property previously generated by MPG and the LDC. IMD will undertake assay establishment, screening, hit identification and hit validation for LDC using its expertise and technology platform with the largest collection of pure natural products (NAT-PURER®) and fractionated extracts (PRE-FRACR®).

Other news from the department business & finance

More news from our other portals

All FT-IR spectrometer manufacturers at a glance